Regulatory role of vitamins E and C on extracellular matrix components of the vascular system

Molecular Aspects of Medicine

Volumn 28, Issue 5-6, 2007, Pages 507-537

  Villacorta, Luis ^a   Azzi, Angelo ^b   Zingg, Jean Marc ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Tocopherol; Extracellular matrix; Gene regulation; l Ascorbic acid; Signal transduction; VSMC; Wound repair

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BILE ACID; CARNITINE; CATECHOLAMINE; CHOLESTEROL; CYTOSKELETON PROTEIN; IRON; LIPID; LOW DENSITY LIPOPROTEIN; PEPTIDE HORMONE; VITAMIN BINDING PROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; INFLAMMATION; IRON ABSORPTION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; WOUND HEALING;

ANIMALS; ASCORBIC ACID; BLOOD VESSELS; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX; HUMANS; VITAMIN E;

EID: 35448950829     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.05.002     Document Type: Review

References (195)

1. Abe H., Iehara N., Utsunomiya K., Kita T., and Doi T. A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-beta type II receptor-mediated manner. J. Biol. Chem. 274 30 (1999) 20874-20878
2. Abudu N., Miller J.J., Attaelmannan M., and Levinson S.S. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin. Chim. Acta 339 1-2 (2004) 11-25
3. Alcain F.J., and Buron M.I. Ascorbate on cell growth and differentiation. J. Bioenergy Biomembr. 26 4 (1994) 393-398
4. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90 17 (1994) 7915-7922
5. Antoniades C., Tousoulis D., Tentolouris C., Toutouzas P., and Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 28 7 (2003) 628-638
6. Arakawa E., Hasegawa K., Yanai N., Obinata M., and Matsuda Y. A mouse bone marrow stromal cell line, TBR-B, shows inducible expression of smooth muscle-specific genes. FEBS Lett. 481 2 (2000) 193-196
7. Aratri E., Spycher S.E., Breyer I., and Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett. 447 1 (1999) 91-94
8. Arrigoni O., and De Tullio M.C. Ascorbic acid: much more than just an antioxidant. Biochim. Biophys. Acta 1569 1-3 (2002) 1-9
9. Axel D.I., Frigge A., Dittmann J., Runge H., Spyridopoulos I., Riessen R., Viebahn R., and Karsch K.R. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc. Res. 49 4 (2001) 851-862
10. Azzi A., Boscoboinik D., Marilley D., Ozer N.K., Stauble B., and Tasinato A. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62 Suppl. 6 (1995) 1337S-1346S
11. Azzi A., Breyer I., Feher M., Ricciarelli R., Stocker A., Zimmer S., and Zingg J. Nonantioxidant functions of alpha-tocopherol in smooth muscle cells. J. Nutr. 131 2 (2001) 378S-381S
12. Azzi A., Ricciarelli R., and Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 519 1-3 (2002) 8-10
13. Azzi A., Gysin R., Kempna P., Ricciarelli R., Villacorta L., Visarius T., and Zingg J.M. The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events. Mol. Aspect Med. 24 6 (2003) 325-336
14. Balaban R.S., Nemoto S., and Finkel T. Mitochondria, oxidants, and aging. Cell 120 4 (2005) 483-495
15. Besnard S., Bakouche J., Lemaigre-Dubreuil Y., Mariani J., Tedgui A., and Henrion D. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circ. Res. 90 7 (2002) 820-825
16. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 8 (2007) 842-857
17. Blom I.E., van Dijk A.J., Wieten L., Duran K., Ito Y., Kleij L., deNichilo M., Rabelink T.J., Weening J.J., Aten J., et al. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol. Dial. Transplant. 16 6 (2001) 1139-1148
18. Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 305 3 (2003) 737-740
19. Brigelius-Flohe R., and Traber M.G. Vitamin E: function and metabolism. FASEB J. 13 10 (1999) 1145-1155
20. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., and Azzi A. The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 76 4 (2002) 703-716
21. Brown B.G., and Crowley J. Is there any hope for vitamin E?. JAMA 293 11 (2005) 1387-1390
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 6865 (2001) 813-820
23. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300 2 (1993) 535-543
24. Burk R.F., Christensen J.M., Maguire M.J., Austin L.M., Whetsell Jr. W.O., May J.M., Hill K.E., and Ebner F.F. A combined deficiency of vitamins E and C causes severe central nervous system damage in guinea pigs. J. Nutr. 136 6 (2006) 1576-1581
25. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo M.A., and Leger C.L. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 273 49 (1998) 32801-32805
26. Cameron E., and Pauling L. Ascorbic acid and the glycosaminoglycans. An orthomolecular approach to cancer and other diseases. Oncology 27 2 (1973) 181-192
27. Campbell S.E., Stone W.L., Whaley S.G., Qui M., and Krishnan K. Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer 3 1 (2003) 25
28. Carlberg C. Lipid soluble vitamins in gene regulation. Biofactors 10 2-3 (1999) 91-97
29. Carr A.C., and Frei B. Does vitamin C act as pro-oxidant under physiological conditions?. FASEB J. 13 (1999) 1007-1024
30. Carr A.C., Zhu B.Z., and Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 87 5 (2000) 349-354
31. Chan A.C. Partners in defense, vitamin E and vitamin C. Can. J. Physiol. Pharmacol. 71 9 (1993) 725-731
32. Chen C.C., Chen N., and Lau L.F. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 276 13 (2001) 10443-10452
33. Chiquet M., Renedo A.S., Huber F., and Fluck M. How do fibroblasts translate mechanical signals into changes in extracellular matrix production?. Matrix Biol. 22 1 (2003) 73-80
34. Christen T., Bochaton-Piallat M.L., Neuville P., Rensen S., Redard M., van Eys G., and Gabbiani G. Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation. Circ. Res. 85 1 (1999) 99-107
35. Cicha I., Yilmaz A., Klein M., Raithel D., Brigstock D.R., Daniel W.G., Goppelt-Struebe M., and Garlichs C.D. Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 25 5 (2005) 1008-1013
36. Cyrus T., Yao Y., Rokach J., Tang L.X., and Pratico D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 107 4 (2003) 521-523
37. Davidson J.M., LuValle P.A., Zoia O., Quaglino Jr. D., and Giro M. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J. Biol. Chem. 272 1 (1997) 345-352
38. de Clerck Y.A., and Jones P.A. The effect of ascorbic acid on the nature and production of collagen and elastin by rat smooth-muscle cells. Biochem. J. 186 1 (1980) 217-225
39. DeClerck Y.A., and Jones P.A. Effect of ascorbic acid on the resistance of the extracellular matrix to hydrolysis by tumor cells. Cancer Res. 40 9 (1980) 3228-3231
40. Del Bello B., Maellaro E., Sugherini L., Santucci A., Comporti M., and Casini A.F. Purification of NADPH-dependent dehydroascorbate reductase from rat liver and its identification with 3alpha-hydroxysteroid dehydrogenase. Biochem. J. 304 Pt. 2 (1994) 385-390
41. De Pascale M.C., Bassi A.M., Patrone V., Villacorta L., Azzi A., and Zingg J.M. Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch. Biochem. Biophys. 447 2 (2006) 97-106
42. Diez-Juan A., and Andres V. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis. FASEB J. 15 11 (2001) 1989-1995
43. Doring F., Rimbach G., and Lodge J.K. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life 56 10 (2004) 615-620
44. Engler M.M., Engler M.B., Malloy M.J., Chiu E.Y., Schloetter M.C., Paul S.M., Stuehlinger M., Lin K.Y., Cooke J.P., Morrow J.D., et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 108 9 (2003) 1059-1063
45. Enstrom J.E., Kanim L.E., and Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3 3 (1992) 194-202
46. Erichsen H.C., Engel S.A., Eck P.K., Welch R., Yeager M., Levine M., Siega-Riz A.M., Olshan A.F., and Chanock S.J. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am. J. Epidemiol. 163 3 (2006) 245-254
47. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein M., Behrendt D., Suh J., Frei B., Mudge G.H., Selwyn A.P., et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359 9312 (2002) 1108-1113
48. Folger P.A., Zekaria D., Grotendorst G., and Masur S.K. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest. Ophthalmol. Vis. Sci. 42 11 (2001) 2534-2541
49. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86 16 (1989) 6377-6381
50. Frei B., Keaney Jr. J.F., Retsky K.L., and Chen K. Vitamins C and E and LDL oxidation. Vitam. Horm. 52 (1996) 1-34
51. Fuller C.J., May M.A., and Martin K.J. The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers. J. Am. Coll. Nutr. 19 3 (2000) 361-369
52. Gale C.R., Martyn C.N., Winter P.D., and Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310 6994 (1995) 1563-1566
53. Ganta D.R., McCarthy M.B., and Gronowicz G.A. Ascorbic acid alters collagen integrins in bone culture. Endocrinology 138 9 (1997) 3606-3612
54. Geesin J.C., Darr D., Kaufman R., Murad S., and Pinnell S.R. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J. Invest. Dermatol. 90 4 (1988) 420-424
55. Ghosh P.K., Vasanji A., Murugesan G., Eppell S.J., Graham L.M., and Fox P.L. Membrane microviscosity regulates endothelial cell motility. Nat. Cell Biol. 4 11 (2002) 894-900
56. Ginter E., Bobek P., Kubec F., Vozar J., and Urbanova D. Vitamin C in the control of hypercholesterolemia in man. Int. J. Vitam. Nutr. Res. Suppl. 23 (1982) 137-152
57. Gohil K., Schock B.C., Chakraborty A.A., Terasawa Y., Raber J., Farese Jr. R.V., Packer L., Cross C.E., and Traber M.G. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic. Biol. Med. 35 11 (2003) 1343-1354
58. Goswami T., Rolfs A., and Hediger M.A. Iron transport: emerging roles in health and disease. Biochem. Cell Biol. 80 5 (2002) 679-689
59. Greenwald R.A., and Moy W.W. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 23 4 (1980) 455-463
60. Grotendorst G.R., Okochi H., and Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7 4 (1996) 469-480
61. Habermehl D., Kempna P., Azzi A., and Zingg J.M. Recombinant SEC14-like proteins (TAP) possess GTPase activity. Biochem. Biophys. Res. Commun. 326 1 (2005) 254-259
62. Hallberg L., Brune M., and Rossander L. The role of vitamin C in iron absorption. Int. J. Vitam. Nutr. Res. Suppl. 30 (1989) 103-108
63. Haller H., Lindschau C., Quass P., Distler A., and Luft F.C. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ. Res. 76 1 (1995) 21-29
64. Halpner A.D., Handelman G.J., Harris J.M., Belmont C.A., and Blumberg J.B. Protection by vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch. Biochem. Biophys. 359 2 (1998) 305-309
65. Hathcock J.N., Azzi A., Blumberg J., Bray T., Dickinson A., Frei B., Jialal I., Johnston C.S., Kelly F.J., and Kraemer K. Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr. 81 4 (2005) 736-745
66. Hayden K.M., Welsh-Bohmer K.A., Wengreen H.J., Zandi P.P., Lyketsos C.G., and Breitner J.C. Risk of mortality with vitamin E supplements: the Cache County study. Am. J. Med. 120 2 (2007) 180-184
67. Heller R., Hecker M., Stahmann N., Thiele J.J., Werner-Felmayer G., and Werner E.R. Alpha-tocopherol amplifies phosphorylation of endothelial nitric oxide synthase at serine 1177 and its short-chain derivative trolox stabilizes tetrahydrobiopterin. Free Radic. Biol. Med. 37 5 (2004) 620-631
68. Heller R., Werner-Felmayer G., and Werner E.R. Alpha-tocopherol and endothelial nitric oxide synthesis. Ann. N.Y. Acad. Sci. 1031 (2004) 74-85
69. Hellman L., and Burns J.J. Metabolism of l-ascorbic acid-1-C14 in man. J. Biol. Chem. 230 2 (1958) 923-930
70. Hulse J.D., Ellis S.R., and Henderson L.M. Carnitine biosynthesis. Beta-hydroxylation of trimethyllysine by an alpha-ketoglutarate-dependent mitochondrial dioxygenase. J. Biol. Chem. 253 5 (1978) 1654-1659
71. Ivanov V.O., Ivanova S.V., and Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J. Mol. Cell. Cardiol. 29 12 (1997) 3293-3303
72. Jacob R.A. Vitamin C nutriture and risk of atherosclerotic heart disease. Nutr. Rev. 56 11 (1998) 334-337
73. Jessup W., Kritharides L., and Stocker R. Lipid oxidation in atherogenesis: an overview. Biochem. Soc. Trans. 32 Pt. 1 (2004) 134-138
74. Jialal I., and Devaraj S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107 7 (2003) 926-928
75. Jialal I., and Fuller C.J. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can. J. Cardiol. 11 Suppl. G (1995) 97G-103G
76. Jialal I., Vega G.L., and Grundy S.M. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82 3 (1990) 185-191
77. Kagan V.E., Serbinova E.A., Forte T., Scita G., and Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33 3 (1992) 385-397
78. Kashiwada K., Nishida W., Hayashi K., Ozawa K., Yamanaka Y., Saga H., Yamashita T., Tohyama M., Shimada S., Sato K., et al. Coordinate expression of alpha-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells. J. Biol. Chem. 272 24 (1997) 15396-15404
79. Kaul N., Devaraj S., and Jialal I. Alpha-tocopherol and atherosclerosis. Exp. Biol. Med. (Maywood) 226 1 (2001) 5-12
80. Kazi M., Lundmark K., Religa P., Gouda I., Larm O., Ray A., Swedenborg J., and Hedin U. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. J. Cell. Physiol. 193 3 (2002) 365-372
81. Keaney Jr. J.F., Gaziano J.M., Xu A., Frei B., Curran-Celentano J., Shwaery G.T., Loscalzo J., and Vita J.A. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93 2 (1994) 844-851
82. Keaney J.F., Guo Y., Cunningham D., Shwaery G.T., Xu A., and Vita J.A. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J. Clin. Invest. 98 2 (1996) 386-394
83. Kempna P., Zingg J.M., Ricciarelli R., Hierl M., Saxena S., and Azzi A. Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties. Free Radic. Biol. Med. 34 11 (2003) 1458-1472
84. Kinlay S., Behrendt D., Fang J.C., Delagrange D., Morrow J., Witztum J.L., Rifai N., Selwyn A.P., Creager M.A., and Ganz P. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J. Am. Coll. Cardiol. 43 4 (2004) 629-634
85. Klee C.B., Ren H., and Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem. 273 22 (1998) 13367-13370
86. Knekt P., Reunanen A., Jarvinen R., Seppanen R., Heliovaara M., and Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139 12 (1994) 1180-1189
87. Kocher O., Gabbiani F., Gabbiani G., Reidy M.A., Cokay M.S., Peters H., and Huttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab. Invest. 65 4 (1991) 459-470
88. Koya D., Lee I.K., Ishii H., Kanoh H., and King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8 3 (1997) 426-435
89. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., and Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87 6 (1996) 1069-1078
90. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85 8 (1999) 753-766
91. Kurata S., Senoo H., and Hata R. Transcriptional activation of type I collagen genes by ascorbic acid 2-phosphate in human skin fibroblasts and its failure in cells from a patient with alpha 2(I)-chain-defective Ehlers-Danlos syndrome. Exp. Cell. Res. 206 1 (1993) 63-71
92. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., Glatt H., and Brigelius-Flohe R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65 2 (2003) 269-273
93. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., and Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 1 (2005) 56-65
94. Lehr H.A., Frei B., and Arfors K.E. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc. Natl. Acad. Sci. USA 91 16 (1994) 7688-7692
95. Lehr H.A., Frei B., Olofsson A.M., Carew T.E., and Arfors K.E. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 91 5 (1995) 1525-1532
96. Lehr H.A., Weyrich A.S., Saetzler R.K., Jurek A., Arfors K.E., Zimmerman G.A., Prescott S.M., and McIntyre T.M. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J. Clin. Invest. 99 10 (1997) 2358-2364
97. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N. Engl. J. Med. 314 14 (1986) 892-902
98. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., and Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106 4 (2000) 523-531
99. Li W., Hellsten A., Jacobsson L.S., Blomqvist H.M., Olsson A.G., and Yuan X.M. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J. Mol. Cell. Cardiol. 37 5 (2004) 969-978
100. Liu L., and Meydani M. Combined vitamins C and E supplementation retards early progression of arteriosclerosis in heart transplant patients. Nutr. Rev. 60 11 (2002) 368-371
101. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 11 (2005) 1338-1347
102. Lynch S.M., Gaziano J.M., and Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. Subcell Biochem. 25 (1996) 331-367
103. Maeda N., Hagihara H., Nakata Y., Hiller S., Wilder J., and Reddick R. Aortic wall damage in mice unable to synthesize ascorbic acid. Proc. Natl. Acad. Sci. USA 97 2 (2000) 841-846
104. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol. Res. 40 3 (1999) 227-238
105. Martin A., and Frei B. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17 8 (1997) 1583-1590
106. Mauch S., Kolb C., Kolb B., Sadowski T., and Sedlacek R. Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J. Immunol. 168 3 (2002) 1244-1251
107. May J.M. Is ascorbic acid an antioxidant for the plasma membrane?. FASEB J. 13 9 (1999) 995-1006
108. May J.M., Cobb C.E., Mendiratta S., Hill K.E., and Burk R.F. Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. J. Biol. Chem. 273 36 (1998) 23039-23045
109. May J.M., Qu Z.C., and Cobb C.E. Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydroascorbic acid. J. Biol. Chem. 279 15 (2004) 14975-14982
110. McQuillan B.M., Hung J., Beilby J.P., Nidorf M., and Thompson P.L. Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). J. Am. Coll. Cardiol. 38 7 (2001) 1788-1794
111. Micheletta F., Natoli S., Misuraca M., Sbarigia E., Diczfalusy U., and Iuliano L. Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler. Thromb. Vasc. Biol. 24 1 (2004) 136-140
112. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 1 (2005) 37-46
113. Munteanu A., Zingg J.M., and Azzi A. Anti-atherosclerotic effects of vitamin E - myth or reality?. J. Cell. Mol. Med. 8 1 (2004) 59-76
114. Munteanu A., Taddei M., Tamburini I., Bergamini E., Azzi A., and Zingg J.M. Antagonistic effects of oxidized low density lipoprotein and {alpha}-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-{gamma}. J. Biol. Chem. 281 10 (2006) 6489-6497
115. Naidu K.A. Vitamin C in human health and disease is still a mystery? An overview. Nutr. J. 2 1 (2003) 7
116. Nakata Y., and Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation 105 12 (2002) 1485-1490
117. Napoli C., Williams-Ignarro S., De Nigris F., Lerman L.O., Rossi L., Guarino C., Mansueto G., Di Tuoro F., Pignalosa O., De Rosa G., et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 101 23 (2004) 8797-8802
118. Ness A., Egger M., and Smith G.D. Role of antioxidant vitamins in prevention of cardiovascular diseases. Meta-analysis seems to exclude benefit of vitamin C supplementation. BMJ 319 7209 (1999) 577
119. Neuville P., Geinoz A., Benzonana G., Redard M., Gabbiani F., Ropraz P., and Gabbiani G. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am. J. Pathol. 150 2 (1997) 509-521
120. Neuzil J., Dong L.F., Wang X.F., and Zingg J.M. Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Biochem. Biophys. Res. Commun. 343 4 (2006) 1113-1117
121. Nier B., Weinberg P.D., Rimbach G., Stocklin E., and Barella L. Differential gene expression in skeletal muscle of rats with vitamin E deficiency. IUBMB Life 58 9 (2006) 540-548
122. Nusgens B.V., Humbert P., Rougier A., Colige A.C., Haftek M., Lambert C.A., Richard A., Creidi P., and Lapiere C.M. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J. Invest. Dermatol. 116 6 (2001) 853-859
123. Oemar B.S., and Luscher T.F. Connective tissue growth factor. Friend or foe?. Arterioscler. Thromb. Vasc. Biol. 17 8 (1997) 1483-1489
124. Oemar B.S., Werner A., Garnier J.M., Do D.D., Godoy N., Nauck M., Marz W., Rupp J., Pech M., and Luscher T.F. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95 4 (1997) 831-839
125. Oommen S., Vasu V.T., Leonard S.W., Traber M.G., Cross C.E., and Gohil K. Genome wide responses of murine lungs to dietary alpha-tocopherol. Free Radic. Res. 41 1 (2007) 98-109
126. Orbe J., Rodriguez J.A., Arias R., Belzunce M., Nespereira B., Perez-Ilzarbe M., Roncal C., and Paramo J.A. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167 1 (2003) 45-53
127. Ozer N.K., Boscoboinik D., and Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem. Mol. Biol. Int. 35 1 (1995) 117-124
128. Padayatty S.J., Katz A., Wang Y., Eck P., Kwon O., Lee J.H., Chen S., Corpe C., Dutta A., Dutta S.K., et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 22 1 (2003) 18-35
129. Padh H. Vitamin C: newer insights into its biochemical functions. Nutr. Rev. 49 3 (1991) 65-70
130. Panagabko C., Morley S., Hernandez M., Cassolato P., Gordon H., Parsons R., Manor D., and Atkinson J. Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42 21 (2003) 6467-6474
131. Pfeffer F., Casanueva E., Kamar J., Guerra A., Perichart O., and Vadillo-Ortega F. Modulation of 72-kDa type IV collagenase (matrix metalloproteinase-2) by ascorbic acid in cultured human amnion-derived cells. Biol. Reprod. 59 2 (1998) 326-329
132. Pinnel S.R., Murad S., and Darr D. Induction of collagen synthesis by ascorbic acid. A possible mechanism. Arch. Dermatol. 123 12 (1987) 1684-1686
133. Porter T.D. Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E (review). J. Nutr. Biochem. 14 1 (2003) 3-6
134. Price K.D., Price C.S., and Reynolds R.D. Hyperglycemia-induced ascorbic acid deficiency promotes endothelial dysfunction and the development of atherosclerosis. Atherosclerosis 158 1 (2001) 1-12
135. Proteggente A.R., Rehman A., Halliwell B., and Rice-Evans C.A. Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo?. Biochem. Biophys. Res. Commun. 277 3 (2000) 535-540
136. Pryor W.A., Houk K.N., Foote C.S., Fukuto J.M., Ignarro L.J., Squadrito G.L., and Davies K.J. Free radical biology and medicine: it's a gas, man!. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 3 (2006) R491-R511
137. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int. J. Exp. Pathol. 81 3 (2000) 173-182
138. Rask-Madsen C., and King G.L. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 25 3 (2005) 487-496
139. Rayment S.J., Shaw J., Woollard K.J., Lunec J., and Griffiths H.R. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem. Biophys. Res. Commun. 308 2 (2003) 339-345
140. Rebouche C.J. Ascorbic acid and carnitine biosynthesis. Am. J. Clin. Nutr. 54 Suppl. 6 (1991) 1147S-1152S
141. Ricciarelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., and Azzi A. Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 334 Pt. 1 (1998) 243-249
142. Ricciarelli R., Maroni P., Ozer N., Zingg J.M., and Azzi A. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic. Biol. Med. 27 7-8 (1999) 729-737
143. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells. Circulation 102 1 (2000) 82-87
144. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J. 15 13 (2001) 2314-2325
145. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328 20 (1993) 1450-1456
146. Rodriguez-Porcel M., Lerman L.O., Holmes Jr. D.R., Richardson D., Napoli C., and Lerman A. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc. Res. 53 4 (2002) 1010-1018
147. Rose R.C., and Bode A.M. Biology of free radical scavengers: an evaluation of ascorbate. FASEB J. 7 12 (1993) 1135-1142
148. Rosenfeld L. Vitamine-vitamin. The early years of discovery. Clin. Chem. 43 4 (1997) 680-685
149. Saari J.C., Nawrot M., Kennedy B.N., Garwin G.G., Hurley J.B., Huang J., Possin D.E., and Crabb J.W. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron 29 3 (2001) 739-748
150. Salonen J.T., Nyyssonen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Lakka T.A., Rissanen T., Leskinen L., et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med. 248 5 (2000) 377-386
151. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Lakka H.M., et al. Six-year effect of combined vitamins C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107 7 (2003) 947-953
152. Samuni A., Aronovitch J., Godinger D., Chevion M., and Czapski G. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur. J. Biochem. 137 1-2 (1983) 119-124
153. Sato K., Niki E., and Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophys. 279 2 (1990) 402-405
154. Sayed-Ahmed M.M., Khattab M.M., Gad M.Z., and Mostafa N. l-Carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits. Pharmacol. Res. 44 3 (2001) 235-242
155. Schule R., Rangarajan P., Yang N., Kliewer S., Ransone L.J., Bolado J., Verma I.M., and Evans R.M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA 88 14 (1991) 6092-6096
156. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 7 (1996) 709-720
157. Seno T., Inoue N., Matsui K., Ejiri J., Hirata K., Kawashima S., and Yokoyama M. Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J. Vasc. Res. 41 4 (2004) 345-351
158. Sharma M.K., and Buettner G.R. Interaction of vitamin C and vitamin E during free radical stress in plasma: an ESR study. Free Radic. Biol. Med. 14 6 (1993) 649-653
159. Shinomiya K., Fukunaga M., Kiyomoto H., Mizushige K., Tsuji T., Noma T., Ohmori K., Kohno M., and Senda S. A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens. Res. 25 1 (2002) 91-98
160. Siow R.C., Richards J.P., Pedley K.C., Leake D.S., and Mann G.E. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler. Thromb. Vasc. Biol. 19 10 (1999) 2387-2394
161. Siow R.C., Sato H., Leake D.S., Ishii T., Bannai S., and Mann G.E. Induction of antioxidant stress proteins in vascular endothelial and smooth muscle cells: protective action of vitamin C against atherogenic lipoproteins. Free Radic. Res. 31 4 (1999) 309-318
162. Sirikci O., Ozer N.K., and Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 126 2 (1996) 253-263
163. Stadtman E.R. Ascorbic acid and oxidative inactivation of proteins. Am. J. Clin. Nutr. 54 Suppl 6. (1991) 1125S-1128S
164. Stahl W., Ale-Agha N., and Polidori M.C. Non-antioxidant properties of carotenoids. Biol. Chem. 383 3-4 (2002) 553-558
165. Stauble B., Boscoboinik D., Tasinato A., and Azzi A. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and d-alpha-tocopherol in vascular smooth muscle cells. Eur. J. Biochem. 226 2 (1994) 393-402
166. Steinberg D. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?. Curr. Opin. Lipidol. 11 6 (2000) 603-607
167. Suarna C., Wu B.J., Choy K., Mori T., Croft K., Cynshi O., and Stocker R. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic. Biol. Med. 41 5 (2006) 722-730
168. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21 3 (1996) 335-348
169. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., and Lee R.T. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107 14 (2003) 1912-1916
170. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., and Azzi A. d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA 92 26 (1995) 12190-12194
171. Terasawa Y., Ladha Z., Leonard S.W., Morrow J.D., Newland D., Sanan D., Packer L., Traber M.G., and Farese Jr. R.V. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc. Natl. Acad. Sci. USA 97 25 (2000) 13830-13834
172. Teucher B., Olivares M., and Cori H. Enhancers of iron absorption: ascorbic acid and other organic acids. Int. J. Vitam. Nutr. Res. 74 6 (2004) 403-419
173. Tinker D., and Rucker R.B. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Physiol. Rev. 65 3 (1985) 607-657
174. Tousoulis D., Davies G., and Toutouzas P. Vitamin C increases nitric oxide availability in coronary atherosclerosis. Ann. Intern. Med. 131 2 (1999) 156-157
175. Toutouzas P.C., Tousoulis D., and Davies G.J. Nitric oxide synthesis in atherosclerosis. Eur. Heart J. 19 10 (1998) 1504-1511
176. Ulrich-Merzenich G., Metzner C., Schiermeyer B., and Vetter H. Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur. J. Nutr. 41 1 (2002) 27-34
177. Upston J.M., Kritharides L., and Stocker R. The role of vitamin E in atherosclerosis. Prog. Lipid Res. 42 5 (2003) 405-422
178. van Aalst J.A., Burmeister W., Fox P.L., and Graham L.M. Alpha-tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity. J. Vasc. Surg. 39 1 (2004) 229-237
179. Villacorta L., Graca-Souza A.V., Ricciarelli R., Zingg J.M., and Azzi A. Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells. Circ. Res. 92 1 (2003) 104-110
180. Wang X., Culotta V.C., and Klee C.B. Superoxide dismutase protects calcineurin from inactivation. Nature 383 6599 (1996) 434-437
181. Wang X., LeMaire S.A., Chen L., Shen Y.H., Gan Y., Bartsch H., Carter S.A., Utama B., Ou H., Coselli J.S., et al. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 114 Suppl. 1 (2006) I200-I205
182. Washburn M.P., and Wells W.W. The catalytic mechanism of the glutathione-dependent dehydroascorbate reductase activity of thioltransferase (glutaredoxin). Biochemistry 38 1 (1999) 268-274
183. Way K.J., Katai N., and King G.L. Protein kinase C and the development of diabetic vascular complications. Diab. Med. 18 12 (2001) 945-959
184. Weinberg P.D. Analysis of the variable effect of dietary vitamin E supplements on experimental atherosclerosis. J. Plant Physiol. 162 7 (2005) 823-833
185. Wiegman P.J., Barry W.L., McPherson J.A., McNamara C.A., Gimple L.W., Sanders J.M., Bishop G.G., Powers E.R., Ragosta M., Owens G.K., et al. All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: a favorable effect on vessel remodeling. Arterioscler. Thromb. Vasc. Biol. 20 1 (2000) 89-95
186. Witztum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88 6 (1991) 1785-1792
187. Woollard K.J., Loryman C.J., Meredith E., Bevan R., Shaw J.A., Lunec J., and Griffiths H.R. Effects of oral vitamin C on monocyte: endothelial cell adhesion in healthy subjects. Biochem. Biophys. Res. Commun. 294 5 (2002) 1161-1168
188. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., Li Y., Arita M., Suzuki H., and Mizusawa H. Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. USA 98 26 (2001) 15185-15190
189. You H., Yu W., Sanders B.G., and Kline K. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ. 12 9 (2001) 471-480
190. Yu T., Robotham J.L., and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. USA 103 8 (2006) 2653-2658
191. Zhu X.Y., Rodriguez-Porcel M., Bentley M.D., Chade A.R., Sica V., Napoli C., Caplice N., Ritman E.L., Lerman A., and Lerman L.O. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109 17 (2004) 2109-2115
192. Zimmer S., Stocker A., Sarbolouki M.N., Spycher S.E., Sassoon J., and Azzi A. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 275 33 (2000) 25672-25680
193. Zingg, J.M., 2006. Modulation of signal transduction by vitamin E. In: Davos. Medimond International Proceedings, pp. 47-60.
194. Zingg J.M., and Azzi A. Non-antioxidant activities of vitamin E. Curr. Med. Chem. 11 9 (2004) 1113-1133
195. Zureik M., Galan P., Bertrais S., Mennen L., Czernichow S., Blacher J., Ducimetiere P., and Hercberg S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler. Thromb. Vasc. Biol. 24 8 (2004) 1485-1491